Medicines360 Drug Patent Portfolio
Medicines360 owns 1 orange book drug protected by 4 US patents Given below is the list of Medicines360's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11571328 | IUD insertion devices | 07 Sep, 2040 | Active |
| US10028858 | Intrauterine systems, IUD insertion devices, and related methods and kits therefor | 22 Mar, 2034 | Active |
| US11090186 | Methods for using intrauterine systems and IUD insertion devices | 24 Oct, 2033 | Active |
| US12004992 | Kits for intrauterine systems and IUD insertion devices | 06 Oct, 2033 | Active |
Latest Legal Activities on Medicines360's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Medicines360.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Recordation of Patent Grant Mailed
Critical
| 07 Feb, 2023 | US11571328 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 07 Feb, 2023 | US11571328 |
|
Email Notification
Critical
| 19 Jan, 2023 | US11571328 |
|
Issue Notification Mailed
Critical
| 18 Jan, 2023 | US11571328 |
| Mailing Corrected Notice of Allowability | 06 Jan, 2023 | US11571328 |
|
Email Notification
Critical
| 06 Jan, 2023 | US11571328 |
| Corrected Notice of Allowability | 28 Dec, 2022 | US11571328 |
|
Pubs Case Remand to TC
Critical
| 05 Dec, 2022 | US11571328 |
| Mailing Corrected Notice of Allowability | 02 Dec, 2022 | US11571328 |
|
Email Notification
Critical
| 02 Dec, 2022 | US11571328 |
| Corrected Notice of Allowability | 29 Nov, 2022 | US11571328 |
|
Pubs Case Remand to TC
Critical
| 04 Nov, 2022 | US11571328 |
|
Information Disclosure Statement considered
Critical
| 03 Nov, 2022 | US11571328 |
|
Application Is Considered Ready for Issue
Critical
| 03 Nov, 2022 | US11571328 |
| Dispatch to FDC | 03 Nov, 2022 | US11571328 |
Medicines360 Drug Patents' Oppositions Filed in EPO
Medicines360 drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Jun 11, 2019, by Bayer Intellectual Property Gmbh / Bayer Oy / Bayerag. This opposition was filed on patent number EP12811921A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
 | |||
| EP12811921A | Jun, 2019 | Bayer Intellectual Property GmbH / Bayer Oy / BayerAG | Patent maintained as amended |
Medicines360's Family Patents
Medicines360 Drug List
Given below is the complete list of Medicines360's drugs and the patents protecting them.
1. Liletta
Liletta is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11571328 | IUD insertion devices |
07 Sep, 2040
(15 years from now)
| Active |
| US10028858 | Intrauterine systems, IUD insertion devices, and related methods and kits therefor |
22 Mar, 2034
(9 years from now)
| Active |
| US11090186 | Methods for using intrauterine systems and IUD insertion devices |
24 Oct, 2033
(8 years from now)
| Active |
| US12004992 | Kits for intrauterine systems and IUD insertion devices |
06 Oct, 2033
(8 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Liletta's drug page